United Therapeutics Corporation: accounts_receivable
| Value | {"amount": 151400000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2019-12-31) |
| Status | current |
| Entity | United Therapeutics Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:44:46.340152+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9b77c779-6e9a-4843-8d04-eb19af52ab52
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-20-025009Retrieved: 2026-08-19T10:44:46.340152+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001082554/accounts-receivable/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9b77c779-6e9a-4843-8d04-eb19af52ab52
History
- no predecessors — first report